Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Sep 26, 2023
Walvax and RNAcure Announce Safety, Immunogenicity and Efficacy Data from Phase 3b Clinical Study of RQ3013 (SARS-CoV-2 Variants mRNA Vaccine) Published in eClinicalMedicine
Learn More
Aug 5, 2024
Walrinvax™ Pre-Qualified by WHO
Learn More
Oct 24, 2025
Walvax's 13-Valent Pneumococcal Vaccine Taps into Malaysia
Learn More